Efficacy & Safety of Lanreotide Microparticles as Palliative Treatment in

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05283226` - Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy	Phase 2
Active, not recruiting	`NCT04362072` - Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer	Phase 4
Completed	`NCT04033991` - Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.
Recruiting	`NCT02292641` - Beyond TME Origins	N/A
Not yet recruiting	`NCT02907606` - Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study	N/A
Completed	`NCT02507544` - A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer	Phase 1
Completed	`NCT01942200` - A Non Interventional Study With Oxaliplatin Onkovis (Oxaliplatin) Utilized for the Treatment of Cancer
Completed	`NCT01061645` - Study of MOC31-PE in Antigen Positive Carcinomas	Phase 1
Terminated	`NCT00557596` - A Phase 1-2, XIAP Antisense AEG35156 With Gemcitabine in Patients With Advanced Pancreatic Cancer	Phase 1/Phase 2
Completed	`NCT00532155` - A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer	Phase 3
Recruiting	`NCT06022757` - Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19)	Phase 1/Phase 2
Recruiting	`NCT05520281` - Short-term Psychodynamic Psychotherapy in Serious Physical Illness	N/A
Recruiting	`NCT05752357` - The Role of Pre-operative and Post-operative Circulating Tumor Cells in Gastric Cancer.
Not yet recruiting	`NCT05023928` - Tumor Antigen-sensitized DC Vaccine as an Adjuvant Therapy for Esophagus Cancer	Phase 1
Completed	`NCT00446446` - PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)	Phase 2
Recruiting	`NCT04566952` - Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer	Phase 2
Not yet recruiting	`NCT06112041` - The Prospective Clinical Study of Precision PRaG Therapy in Elderly Patients With Advanced Solid Malignant Tumors (PRaG9.0)	Phase 2
Completed	`NCT03562897` - Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer	Phase 2
Recruiting	`NCT06013111` - An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-CEA-CAR-T Cells Injection in Patients With CEA+ Locally Advanced and/or Metastatic Solid Tumors	Phase 1
Active, not recruiting	`NCT04600206` - Existential Distress in Patients With Advanced Cancer and Their Caregivers

NCT number	NCT00216372
Study type	Interventional
Source	Ipsen
Contact
Status	Completed
Phase	Phase 3
Start date	September 2003
Completion date	October 2008

Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms